News Trump's budget would be "catastrophic" for federal R&D Trump's 2026 budget request envisages sweeping cuts to funding for the NIH and other federal agencies that will be a disaster, say science advocates.
Sales & Marketing How can the pharma industry address the gap in talent recrui... Across the economy, several industries have seen a significant increase in staff turnover due to several factors including the COVID-19 pandemic, burnout, and increasing demand for workplac
Views & Analysis How can the pharma industry navigate issues in the global su... Supply chain shortages have dominated headlines for several months, and the pharma industry has been no exception.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.